|
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 5.060 CNY | 0.00% |
|
-1.94% | -1.17% |
| 07-16 | Jointown Pharmaceutical's Two Drugs Added to China's Essential Medicines List | MT |
| 06-11 | Jointown Pharma Issues 1 Billion Yuan in Asset-Backed Securities | MT |
Company Valuation: Jointown Pharmaceutical Group Co., Ltd
Data adjusted to current consolidation scope
| Fiscal Period: December | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|---|---|---|
| Market Cap 1 | 26,919 | 24,052 | 26,691 | 25,148 | 25,531 | 25,231 | - | - |
| Change | - | -10.65% | 10.97% | -5.78% | 1.52% | -1.17% | - | - |
| Enterprise Value (EV) 1 | 29,021 | 21,882 | 24,319 | 20,414 | 20,954 | 20,911 | 20,188 | 20,162 |
| Change | - | -24.6% | 11.14% | -16.06% | 2.65% | -0.21% | -3.45% | -0.13% |
| P/E | 11.6x | 12.2x | 12.7x | 10.2x | 11.6x | 10.8x | 9.98x | 8.99x |
| PBR | 1.31x | 1.09x | 1.14x | 0.95x | 0.96x | 0.85x | 0.81x | 0.77x |
| PEG | - | -0.8x | 1.76x | 0.6x | -1x | 1.74x | 1.17x | 0.8x |
| Capitalization / Revenue | 0.22x | 0.17x | 0.18x | 0.17x | 0.16x | 0.15x | 0.14x | 0.13x |
| EV / Revenue | 0.24x | 0.16x | 0.16x | 0.13x | 0.13x | 0.12x | 0.11x | 0.11x |
| EV / EBITDA | 6.93x | 6.21x | 6.5x | 4.61x | 5.18x | 4.49x | 3.75x | 3.25x |
| EV / EBIT | 8.08x | 7.67x | 8.05x | 5.62x | 6.34x | 5.88x | 5.22x | 4.67x |
| EV / FCF | - | - | - | - | - | - | - | - |
| FCF Yield | - | - | - | - | - | - | - | - |
| Dividend per Share 2 | 0.1115 | 0.1858 | 0.1938 | 0.2 | 0.2 | 0.2088 | 0.2228 | 0.2503 |
| Rate of return | 2.04% | 3.83% | 3.57% | 3.91% | 3.91% | 4.13% | 4.4% | 4.95% |
| EPS 2 | 0.472 | 0.3976 | 0.4264 | 0.5 | 0.44 | 0.4673 | 0.5072 | 0.5627 |
| Distribution rate | 23.6% | 46.7% | 45.5% | 40% | 45.5% | 44.7% | 43.9% | 44.5% |
| Net sales 1 | 122,407 | 140,424 | 150,140 | 151,810 | 161,390 | 169,796 | 179,819 | 188,754 |
| EBITDA 1 | 4,187 | 3,526 | 3,741 | 4,427 | 4,046 | 4,653 | 5,377 | 6,194 |
| EBIT 1 | 3,593 | 2,853 | 3,023 | 3,635 | 3,306 | 3,558 | 3,867 | 4,315 |
| Net income 1 | 2,448 | 2,085 | 2,174 | 2,507 | 2,255 | 2,356 | 2,558 | 2,828 |
| Net Debt 1 | 2,102 | -2,170 | -2,372 | -4,734 | -4,576 | -4,321 | -5,043 | -5,070 |
| Reference price 2 | 5.470 | 4.846 | 5.434 | 5.120 | 5.120 | 5.060 | 5.060 | 5.060 |
| Nbr of stocks (in thousands) | 4,921,006 | 4,963,416 | 4,911,693 | 4,911,693 | 4,986,434 | 4,986,434 | - | - |
| Announcement Date | 4/25/22 | 4/24/23 | 4/26/24 | 4/28/25 | 4/27/26 | - | - | - |
1CNY in Million2CNY
Estimates
P/E, Detailed evolution
| P/E (Y) | EV / Sales (Y) | EV / EBITDA (Y) | Dividend Yield (Y) | Capi.($) | ||
|---|---|---|---|---|---|---|
| 10.83x | 0.12x | 4.49x | 4.13% | 3.73B | ||
| 19.25x | 0.23x | 13.33x | 0.41% | 95.31B | ||
| 28.35x | 0.22x | 14.28x | 0.94% | 51.65B | ||
| 45.3x | 3.2x | 29.69x | 1.37% | 23.26B | ||
| 11.72x | 0.2x | 4.91x | 2.58% | 8.29B | ||
| 13.83x | 1.06x | 8.54x | 2.46% | 7.98B | ||
| 5.98x | 0.1x | 2.67x | 4.95% | 6.76B | ||
| 9.38x | 1.76x | 5.6x | 3.5% | 6.29B | ||
| 25.14x | 1.23x | 15.15x | 2.84% | 5.48B | ||
| 14.37x | - | - | 2.37% | 3.6B | ||
| Average | 18.41x | 0.90x | 10.96x | 2.55% | 21.24B | |
| Weighted average by Cap. | 23.02x | 0.66x | 14.18x | 1.2% |
Y-o-Y evolution of P/E
Historical PBR trend
Evolution Enterprise Value / Sales
Change in Enterprise Value/EBITDA
Year-on-year evolution of the Yield
- Stock Market
- Stocks
- 600998 Stock
- Valuation Jointown Pharmaceutical Group Co., Ltd
Select your edition
All financial news and data tailored to specific country editions
















